FDA Inspection 1087148 — Aadhar Health Institute
The FDA completed an inspection of Aadhar Health Institute on Apr 12, 2019 in Hissar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hissar (India)
Additional Details
Clinical BA/BE